Analysts at CRT Capital initiated coverage on shares of St. Jude Medical STJ with a “buy” rating.
The target price for St. Jude Medical is set to $80.
St. Jude Medical shares have jumped 48.45% over the past 52 weeks, while the S&P 500 index has gained 19.69% in the same period.
St. Jude Medical's shares gained 0.27% to close at $70.32 yesterday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in